Abstract
Spinal muscular atrophy (SMA) is a neuromuscular disorder with an autosomal recessive inheritance pattern. Patients with severe symptoms may suffer respiratory failure, leading to death. The homozygous deletion of exon 7 in the SMN1 gene accounts for nearly 95% of all cases. Population carrier screening for SMA and prenatal diagnosis by amniocentesis for high-risk couples can assist in identifying the risk of fetal disease. We provided the SMA carrier screening process to 55,447 pregnant women in Yancheng from October 2020 to December 2022. Among them, 8185 participated in this process, with a participation rate of around 14.76% (95% CI 14.47–15.06%). Quantitative real-time polymerase chain reaction (qPCR) was used to detect deletions of SMN1 exons 7 and 8 (E7, E8) in screened pregnant women. 127 were identified as carriers (111 cases of E7 and E8 heterozygous deletions, 15 cases of E7 heterozygous deletions, and 1 case of E7 heterozygous deletions and E8 homozygous deletions), resulting in a carrying rate of around 1.55% (95% CI 1.30–1.84%). After genetic counseling, 114 spouses of pregnant women who tested positive underwent SMA carrier screening; three of them were screened as SMA carriers. Multiplexed ligation-dependent probe amplification (MLPA) was used for the prenatal diagnosis of the fetuses of high-risk couples. Two of them exhibited two copies of SMN1 exon 7 (normal), and the pregnancy was continued; one exhibited no copies of SMN1 exon 7 and exon 8 (SMA patient), and the pregnancy was terminated. Analyzing SMN1 mutations in Yancheng and provide clinical evidence for SMA genetic counseling and birth defect prevention. Interventional prenatal diagnosis for high-risk families can promote informed reproductive selection and prepare for the fetus’s early treatment.
Similar content being viewed by others
References
Aslesh T, Yokota T (2022) Restoring SMN expression: an overview of the therapeutic developments for the treatment of spinal muscular atrophy. Cells 11:417
Belter L, Jarecki J, Reyna SP et al (2021) The cure SMA membership surveys: highlights of key demographic and clinical characteristics of individuals with spinal muscular atrophy. J Neuromusc Dis 8:109–123
Benlefki S, Younes R, Challuau D et al (2023) Differential effect of fas activation on spinal muscular atrophy motoneuron death and induction of axonal growth: dual signaling of fas in motoneurons. Cell Mol Biol (Noisy-le-grand) 69:1–8
Calucho M, Bernal S, Alías L et al (2018) Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases. Neuromuscul Disord 28:208–215
Chen X, Sanchis-Juan A, French CE et al (2020) Spinal muscular atrophy diagnosis and carrier screening from genome sequencing data. Genet Med 22:945–953
Chiriboga CA (2017) Nusinersen for the treatment of spinal muscular atrophy. Expert Rev Neurother 17:955–962
Curry M, Cruz R, Belter L et al (2021) Awareness screening and referral patterns among pediatricians in the united states related to early clinical features of spinal muscular atrophy (SMA). BMC Pediatr 21:236
Cuscó I, Bernal S, Blasco-Pérez L et al (2020) Practical guidelines to manage discordant situations of SMN2 copy number in patients with spinal muscular atrophy. Neurol Genet 6:e530
Deguise MO, Chehade L, Kothary R (2021) Metabolic dysfunction in spinal muscular atrophy. Int J Mol Sci 22:5913
Huang Z, Yang Q, Ye J et al (2023) Screening and prenatal diagnosis of survival motor neuron gene deletion in pregnant women in Zhaoqing city, Guangdong Province. BMC Med Genomics 16:1–8
Jones CC, Cook SF, Jarecki J et al (2020) Spinal muscular atrophy (SMA) subtype concordance in siblings: findings from the cure SMA cohort. J Neuromusc Dis 7:33–40
Koteswari P, Lakshmi PA, Yaseen M et al (2022) Preterm birth: causes and complications observed in tertiary care hospitals. Cell Mol Biomed Rep 2:202–2012
Kumar B, Barton S, Kordowska J et al (2021) Novel modification of a confirmatory SMA sequencing assay that can be used to determine SMN2 copy number. Int J Neonatal Screen 7:47
Kumar CH, Roy S, Aishwarya T et al (2023) Pregnancy-induced hypertension: risk factors and current treatment strategies. Cell Mol Biomed Rep 3:197–204
Li C, Geng Y, Zhu X et al (2020) The prevalence of spinal muscular atrophy carrier in China: evidences from epidemiological surveys. Medicine 99:e18975
Liu B, Lu Y, Wu B et al (2020) Survival motor neuron gene copy number analysis by exome sequencing: assisting spinal muscular atrophy diagnosis and carrier screening. J Mol Diagn 22:619–628
Mercuri E, Finkel RS, Muntoni F et al (2018) Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord 28:103–115
Mercuri E, Pera MC, Scoto M et al (2020) Spinal muscular atrophy—insights and challenges in the treatment era. Nat Rev Neurol 16:706–715
Moultrie RR, Kish-Doto J, Peay H et al (2016) A review on spinal muscular atrophy: awareness, knowledge, and attitudes. J Genet Couns 25:892–900
Ramos DM, d’Ydewalle C, Gabbeta V et al (2019) Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment. J Clin Investig 129:4817–4831
Schwab ME, Shao S, Zhang L et al (2022) Investigating attitudes toward prenatal diagnosis and fetal therapy for spinal muscular atrophy. Prenat Diagn 42:1409–1419
Su YN, Hung CC, Lin SY, Chen FY et al (2011) Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005–2009: a prospective population-based cohort study. PLoS ONE 6:e17067
Sun Y, Kong X, Zhao Z et al (2020) Mutation analysis of 419 family and prenatal diagnosis of 339 cases of spinal muscular atrophy in China. BMC Med Genet 21:133
Sun Y, Ma S, Xiao J et al (2024) Preconception or prenatal acceptance of SMN1 gene carrier screening and carrier rate of spinal muscular atrophy: a retrospective study in 18,818 reproductive age women in Wuhan area of China. J Assist Reprod Genet 41:127–133
Verhaart IE, Robertson A, Leary R et al (2017) A multi-source approach to determine SMA incidence and research ready population. J Neurol 264:1465–1473
Wadman RI, Jansen MD, Stam M et al (2020) Intragenic and structural variation in the SMN locus and clinical variability in spinal muscular atrophy. Brain Commun 2:fcaa075
Wijaya YOS, Rohmah MA, Niba ETE et al (2021) Phenotypes of SMA patients retaining SMN1 with intragenic mutation. Brain Develop 43:745–758
Wu SW, Tian GL, Yang RL (2023) Expert consensus on newborn screening for spinal muscular atrophy. Zhonghua Yi Xue Za Zhi 103:2075–2081
Zettler B, Estrella E, Liaquat K et al (2022) Evolving approaches to prenatal genetic counseling for spinal muscular atrophy in the new treatment era. J Genet Couns 31:803–814
Zhang J, Wang Y, Ma D et al (2020) Carrier screening and prenatal diagnosis for spinal muscular atrophy in 13,069 Chinese pregnant women. J Mol Diagn 22:817–822
Zhang L, Mo J, Zhou L et al (2024) Carrier screening for spinal muscular atrophy in 22913 Chinese reproductive age women. Mol Genet Genomic Med 12:e2359
Zhao S, Wang Y, Xiu QX et al (2022) Next generation sequencing is a highly reliable method to analyze exon 7 deletion of survival motor neuron 1 (SMN1) gene. Sci Rep 12:223
Zhao Y, Lou J, Fu Y et al (2023) Results of carrier screening for spinal muscular atrophy among 35 145 reproductive-aged individuals from Dongguan region. Chin J Med Genet 40:655–660
Zhou C, Song CL, Huang X et al (2022) Carrier screening and prenatal diagnosis of spinal muscular atrophy among 19297 pregnant women from Foshan region, Guangdong province. Chin J Birth Health Heredity 30:241–245
Acknowledgements
We thank the Biosan Biotech Co., Ltd for technical guidance on MLPA.
Funding
This work was supported by the Medical Science and Technology Development Plan Project in Yancheng City, Jiangsu Province (YK2021054).
Author information
Authors and Affiliations
Contributions
HS and JZ wrote the paper, they contributed equally to this work; JL and ML conceived of and designed study; JL,QZ,YZ,JD, and ML conducted patient sample recruitment and offered genetic counseling; YF,YG,NS, and LZ performed the experiments; JZ,FY,HS,JW,MX, and FY performed data analyses; NA and SZ collected the samples and clinical information.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sun, H., Zheng, J., Zhang, Q. et al. Screening of Spinal Muscular Atrophy Carriers and Prenatal Diagnosis in Pregnant Women in Yancheng, China. Biochem Genet (2024). https://doi.org/10.1007/s10528-024-10775-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10528-024-10775-9